Constitutively translocating cell line

Details for Australian Patent Application No. 2003228956 (hide)

Owner MDS Analytical Technologies (US) Inc.

Inventors Hudson, Christine C.; Oakley, Robert H.

Agent Watermark

Pub. Number AU-B-2003228956

PCT Number PCT/US03/14581

PCT Pub. Number WO2003/097795

Priority 60/401,698 07.08.02 US; 60/379,986 13.05.02 US

Filing date 12 May 2003

Wipo publication date 2 December 2003

Acceptance publication date 1 October 2009

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 14/72 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/401,698 07.08.02 US; 60/379,986 13.05.02 US

29 January 2004 Application Open to Public Inspection

  Published as AU-B-2003228956

1 December 2005 Assignment before Grant

  Xsira Pharmaceuticals, Inc. The application has been assigned to Molecular Devices Corporation

1 December 2005 Change of Name(s) of Applicant(s), Section 104

  Norak Biosciences, Inc. The name of the applicant has been changed to Xsira Pharmaceuticals, Inc.

6 August 2009 Alteration of Name

  The name of the applicant has been altered to MDS Analytical Technologies (US) Inc.

1 October 2009 Application Accepted

  Published as AU-B-2003228956

28 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003228957-Method of screen or pipe expansion downhole without addition of pipe at the surface

2003228955-Capacitive touch sensor architecture with unique sensor bar addressing